Product Images Gabapentin

This appears to be a formula used to calculate creatinine clearance (CLCr) based on body weight and serum creatinine levels. The formula may be specific to female patients, as it includes an adjustment factor of 0.35 for them. However, without additional context or information, it's difficult to determine the exact purpose or application of this formula.*

This appears to be a chart showing the mean pain score for a study with a 4-week dose titration period followed by a 4-week fixed dose period. The study appears to compare a placebo treatment to a treatment with Gabapentin at a dosage of 3600 mg/day. The chart also includes a baseline measurement at week 1.*

This appears to be a structured layout of a medication trial that spans over several weeks. The trial includes a Week Dose Titration Period, followed by a 4 Week Fixed Dose Period. The medication being tested is Gabapentin at two different dosages of 1800 mg/day and 2400 mg/day compared to a placebo. A pain score is measured over the course of the trial at baseline and for 7 weeks.*

This appears to be a data chart composed of percentages and currency values. There are no further details or descriptions provided in the text.*

This is a medication package of Gabapentin 600 mg strength, which contains 96 tablets. The product number is 5956-0.*